LT3119B - Pharmaceutical composition and process for the preparation thereof - Google Patents
Pharmaceutical composition and process for the preparation thereof Download PDFInfo
- Publication number
- LT3119B LT3119B LTIP249A LTIP249A LT3119B LT 3119 B LT3119 B LT 3119B LT IP249 A LTIP249 A LT IP249A LT IP249 A LTIP249 A LT IP249A LT 3119 B LT3119 B LT 3119B
- Authority
- LT
- Lithuania
- Prior art keywords
- inhibitor
- phenyl
- composition
- composition according
- deprenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU914060A HUT63579A (en) | 1991-12-20 | 1991-12-20 | Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes |
Publications (2)
Publication Number | Publication Date |
---|---|
LTIP249A LTIP249A (en) | 1994-07-15 |
LT3119B true LT3119B (en) | 1994-12-27 |
Family
ID=10966728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTIP249A LT3119B (en) | 1991-12-20 | 1992-12-21 | Pharmaceutical composition and process for the preparation thereof |
Country Status (27)
Country | Link |
---|---|
US (1) | US5589513A (ko) |
EP (1) | EP0617615A1 (ko) |
JP (1) | JPH07502730A (ko) |
KR (1) | KR940703655A (ko) |
AU (1) | AU677170B2 (ko) |
BG (1) | BG98827A (ko) |
BR (1) | BR9206950A (ko) |
CA (1) | CA2125776A1 (ko) |
CZ (1) | CZ147494A3 (ko) |
EC (1) | ECSP930933A (ko) |
EE (1) | EE03015B1 (ko) |
FI (1) | FI942932A0 (ko) |
HU (2) | HUT63579A (ko) |
IL (1) | IL104150A (ko) |
LT (1) | LT3119B (ko) |
LV (1) | LV10386B (ko) |
MY (1) | MY111055A (ko) |
NO (1) | NO942303D0 (ko) |
NZ (1) | NZ246384A (ko) |
PH (1) | PH31073A (ko) |
PL (1) | PL172048B1 (ko) |
RO (1) | RO115785B1 (ko) |
RU (1) | RU2125448C1 (ko) |
SI (1) | SI9200404A (ko) |
SK (1) | SK74494A3 (ko) |
WO (1) | WO1993012775A1 (ko) |
ZA (1) | ZA929883B (ko) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5844003A (en) * | 1991-04-04 | 1998-12-01 | Innovations Foundation | Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
US5817336A (en) * | 1993-04-02 | 1998-10-06 | Orion-Yhtyma Oy | Composition containing selegiline |
DE4432610C1 (de) * | 1994-09-13 | 1996-02-01 | Knoll Ag | Verfahren zur Herstellung von Selegilin-Hydrochlorid |
CA2212412A1 (en) | 1995-02-10 | 1996-08-15 | The University Of Toronto Innovations Foundation | Deprenyl compounds for treatment of glaucoma |
JP4499208B2 (ja) | 1998-10-29 | 2010-07-07 | 株式会社フジモト・コーポレーション | 新規な光学活性アミノペンタン誘導体 |
US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
HUP9902482A2 (hu) * | 1999-07-22 | 2002-04-29 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | P-fluoro-selegilin alkalmazása neuroprotektív gyógyszerkészítmények előállítására |
EP2053033A1 (en) * | 2007-10-26 | 2009-04-29 | Bayer Schering Pharma AG | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
DE102009045056A1 (de) * | 2009-09-28 | 2011-03-31 | Henkel Ag & Co. Kgaa | Fleckenvorbehandlungsmittel |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
EP3544614A4 (en) | 2016-11-28 | 2020-08-05 | Lipocine Inc. | ORAL TESTOSTERONE UNDECANOATE THERAPY |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1227447B (de) * | 1962-03-30 | 1966-10-27 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur Herstellung von Phenylisopropylaminen |
HU193662B (en) * | 1983-12-20 | 1987-11-30 | Chinoin Gyogyszer Es Vegyeszet | Process for producing synergetic pharmaceutical composition of antidepressive aktivity |
HU207282B (en) * | 1984-05-31 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them |
ATE55245T1 (de) * | 1986-04-16 | 1990-08-15 | Asta Pharma Ag | Synergistische kombination von amantadin und selegilin. |
HU207280B (en) * | 1986-09-25 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them |
HU197510B (en) * | 1986-12-19 | 1989-04-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick |
US4861800A (en) * | 1987-08-18 | 1989-08-29 | Buyske Donald A | Method for administering the drug deprenyl so as to minimize the danger of side effects |
GB8807504D0 (en) * | 1988-03-29 | 1988-05-05 | Sandoz Ltd | Improvements in/relating to organic compounds |
HU208484B (en) * | 1988-08-17 | 1993-11-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia |
CA2037178A1 (en) * | 1990-02-28 | 1991-08-29 | Albert Walter Brzeczko | Deprenyl/l-dopa/carbidopa pharmaceutical composition |
GB9011767D0 (en) * | 1990-05-25 | 1990-07-18 | Britannia Pharmaceuticals Ltd | Pharmaceutical compositions |
US5169868A (en) * | 1991-03-01 | 1992-12-08 | University Of Saskatchewan | Aliphatic propargylamines as specific mao-b inhibitors |
US5444095A (en) * | 1991-04-04 | 1995-08-22 | University Of Toronto, Innovations Foundation | Use of deprenyl to rescue damaged nerve cells |
HU209605B (en) * | 1991-04-15 | 1994-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for production of wather-free transdermal preparation |
US5326770A (en) * | 1992-07-17 | 1994-07-05 | The Du Pont Merck Pharmaceutical Company | Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals |
-
1991
- 1991-12-20 HU HU914060A patent/HUT63579A/hu unknown
-
1992
- 1992-12-18 CZ CZ941474A patent/CZ147494A3/cs unknown
- 1992-12-18 PL PL92304116A patent/PL172048B1/pl unknown
- 1992-12-18 RO RO94-01015A patent/RO115785B1/ro unknown
- 1992-12-18 RU RU94031161A patent/RU2125448C1/ru active
- 1992-12-18 EP EP93901880A patent/EP0617615A1/en not_active Withdrawn
- 1992-12-18 KR KR1019940702143A patent/KR940703655A/ko active IP Right Grant
- 1992-12-18 NZ NZ246384A patent/NZ246384A/en unknown
- 1992-12-18 SK SK744-94A patent/SK74494A3/sk unknown
- 1992-12-18 JP JP5510411A patent/JPH07502730A/ja active Pending
- 1992-12-18 CA CA002125776A patent/CA2125776A1/en not_active Abandoned
- 1992-12-18 WO PCT/HU1992/000060 patent/WO1993012775A1/en not_active Application Discontinuation
- 1992-12-18 ZA ZA929883A patent/ZA929883B/xx unknown
- 1992-12-18 PH PH45474A patent/PH31073A/en unknown
- 1992-12-18 SI SI9200404A patent/SI9200404A/sl unknown
- 1992-12-18 US US08/256,128 patent/US5589513A/en not_active Expired - Fee Related
- 1992-12-18 IL IL104150A patent/IL104150A/xx not_active IP Right Cessation
- 1992-12-18 MY MYPI92002341A patent/MY111055A/en unknown
- 1992-12-18 AU AU32652/93A patent/AU677170B2/en not_active Ceased
- 1992-12-18 BR BR9206950A patent/BR9206950A/pt not_active Application Discontinuation
- 1992-12-20 LV LVP-92-547A patent/LV10386B/en unknown
- 1992-12-21 LT LTIP249A patent/LT3119B/lt not_active IP Right Cessation
-
1993
- 1993-05-25 EC EC1993000933A patent/ECSP930933A/es unknown
-
1994
- 1994-06-02 BG BG98827A patent/BG98827A/xx unknown
- 1994-06-17 NO NO942303A patent/NO942303D0/no unknown
- 1994-06-17 FI FI942932A patent/FI942932A0/fi unknown
- 1994-08-10 EE EE9400117A patent/EE03015B1/xx unknown
-
1995
- 1995-06-16 HU HU95P/P00218P patent/HU211478A9/hu unknown
Non-Patent Citations (2)
Title |
---|
H. BLASCHKO: "Pharmacol", pages: 415 |
PIACKAR IR KT.: "Psychopharmacology", pages: 3087 |
Also Published As
Publication number | Publication date |
---|---|
AU677170B2 (en) | 1997-04-17 |
AU3265293A (en) | 1993-07-28 |
HU211478A9 (en) | 1995-11-28 |
HU914060D0 (en) | 1992-03-30 |
HUT63579A (en) | 1993-09-28 |
NO942303L (ko) | 1994-08-17 |
ECSP930933A (es) | 1994-04-20 |
FI942932A (fi) | 1994-06-17 |
BR9206950A (pt) | 1995-11-28 |
EP0617615A1 (en) | 1994-10-05 |
RO115785B1 (ro) | 2000-06-30 |
JPH07502730A (ja) | 1995-03-23 |
RU2125448C1 (ru) | 1999-01-27 |
ZA929883B (en) | 1994-05-16 |
US5589513A (en) | 1996-12-31 |
CZ147494A3 (en) | 1995-01-18 |
IL104150A (en) | 1997-11-20 |
PH31073A (en) | 1998-02-05 |
LTIP249A (en) | 1994-07-15 |
LV10386B (en) | 1995-12-20 |
CA2125776A1 (en) | 1993-07-08 |
EE03015B1 (et) | 1997-08-15 |
WO1993012775A1 (en) | 1993-07-08 |
LV10386A (lv) | 1995-02-20 |
NZ246384A (en) | 1996-02-27 |
PL172048B1 (pl) | 1997-07-31 |
SK74494A3 (en) | 1995-01-12 |
MY111055A (en) | 1999-08-30 |
NO942303D0 (no) | 1994-06-17 |
KR940703655A (ko) | 1994-12-12 |
BG98827A (en) | 1995-06-30 |
FI942932A0 (fi) | 1994-06-17 |
SI9200404A (en) | 1993-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT3119B (en) | Pharmaceutical composition and process for the preparation thereof | |
RU2140266C1 (ru) | Фармацевтическая композиция с регулируемым выделением на основе одной или нескольких фармацевтически приемлемых солей гамма-гидроксимасляной кислоты и способ ее получения | |
CN100448439C (zh) | 用于头痛、偏头痛、恶心和呕吐的药物组合物 | |
RU2460526C2 (ru) | Профилактическое или терапевтическое средство для возрастной дегенерации желтого пятна | |
US6191153B1 (en) | Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity | |
NO339794B1 (no) | Beskyttende middel for en retinal neuronal celle med et prostaglandin F2αderivat som aktiv bestanddel | |
JP3852621B2 (ja) | 血管内皮細胞機能改善剤 | |
EP1154762B1 (en) | Pharmaceutical capsule compositions containing loratadine and pseudoephedrine | |
TW200820995A (en) | Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist | |
Woods et al. | Exogenous tyrosine potentiates the methylphenidate-induced increase in extracellular dopamine in the nucleus accumbens: a microdialysis study | |
GR1009541B (el) | Ποσιμα φαρμακευτικα διαλυματα που περιλαμβανουν μελατονινη | |
CZ20021315A3 (cs) | Jednotka dávkování | |
JPH02500596A (ja) | 医薬組成物 | |
ES2461196T3 (es) | Procedimiento para estabilizar una preparación | |
US3360434A (en) | Method for reducing blood pressure with phenylalanine derivatives | |
NZ207768A (en) | Sustained release tablets comprising dipyridamole | |
CZ281691B6 (cs) | Farmaceutický prostředek proti vysokému krevnímu tlaku | |
DK169120B1 (da) | Anvendelse af L-tryptophan og en perifer nedbrydningshæmmer for L-tryptophan til fremstilling af et smertestillende middel | |
RU2543637C2 (ru) | Пролонгированная фармацевтическая композиция гипотензивного действия и способ ее изготовления | |
US5182285A (en) | Cell-protective composition for preventing or treating of peptic ulcer | |
KR0184350B1 (ko) | 오메프라졸 구강점막 부착 정제 조성물 | |
CN116808224A (zh) | 用于治疗血管疾病的化合物组合 | |
US3642993A (en) | Pharmaceutical composition containing 2-methyl - 5 - phenyl - 1 2-dihydro-3h-2-benzazepine for treatment of a condition associated with anxiety or tension | |
SK282448B6 (sk) | Použitie derivátov cystínu | |
HU204997B (en) | Process for producing carrier system suitable for ensuring controlled biological access to dihydropyridines, as well as new oral dosage form ensuring improved biological access |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM9A | Lapsed patents |
Effective date: 19981221 |